CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2. - Chen L; Alexe G; Dharia NV; Ross L; Iniguez AB; Conway AS; Wang EJ; Veschi V; Lam N; Qi J; Gustafson WC; Nasholm N; et al. (The Journal of clinical investigation, 2018)